Advertisement

PharmacoEconomics

, Volume 9, Issue 4, pp 321–331 | Cite as

Do Physicians’ Perceptions of Drug Costs Influence Their Prescribing?

  • Mandy Ryan
  • Brian Yule
  • Christine Bond
  • Ross J. Taylor
Original Research Article Influence of Drug Costs on Prescribing

Summary

This study examines general practitioner (GP) attitudes towards and knowledge of prescribing costs, and the influence of these 2 factors in the doctor’s demand for drugs. The main emphasis of the study is on the influence of perceived cost of drugs on prescribing habits.

A postal questionnaire was sent to all 273 GPprincipals in the Grampian region of Scotland. This questionnaire assessed GPs’ attitudes and knowledge with respect to prescribing costs. Information was also collected on the prescribing habits of 176 of these GPs. This information was linked to look at the influence GPs’ knowledge of drug costs has on their actual prescribing behaviour. Three drug groups were studied: ulcer—healing drugs, pain—killers and penicillins.

The results showed that although most GPs agreed that costs should be borne in mind when prescribing medicines, their actual knowledge of drug costs was often inaccurate. Furthermore, for certain therapeutic groups, prescribing habits are influenced by GPs’ perceptions of drug costs. This implies that GPs are not as averse to considering costs as is often assumed, and that giving GPs better information about drug costs might promote more rational prescribing.

Keywords

Adis International Limited Cimetidine Ranitidine National Health Service Drug Cost 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Office of Health Economics Compendium of Health Statistics. London: Office of Health Economics, 1994Google Scholar
  2. 2.
    Yule B, Fordyce I, Bond C, et al. The ‘limited list’ in general practice: implications for the costs and effectiveness of prescribing. Health Economics Research Unit Discussion Paper No. 01/88. Aberdeen: University of Aberdeen, 1988Google Scholar
  3. 3.
    Harris CM, Heywood PL, Clayden AD. The analysis of prescribing in general practice. London: Her Majesty’s Stationery Office, 1990Google Scholar
  4. 4.
    Scottish Home and Health Department. Introducing Scottish prescribing analysis. Edinburgh: Her Majesty’s Stationery Office, 1990Google Scholar
  5. 5.
    Secretaries of State for Health, Wales, Northern Ireland and Scotland. Working for patients (Cm 555). London: Her Majesty’s Stationery Office, 1989Google Scholar
  6. 6.
    Fowkes FGR. Doctors’ knowledge of the costs of medical care. Med Educ 1985; 19: 113–7PubMedCrossRefGoogle Scholar
  7. 7.
    Rowe J, Mac Vicar S. Doctors’ knowledge of the cost of common medications. J Clin Hosp Pharm 1986; 11: 365–8PubMedGoogle Scholar
  8. 8.
    Ryan M, Yule B, Bond C, et al. Scottish general practitioners’ attitudes and knowledge in respect of prescribing costs. BMJ 1990; 300: 1316–8PubMedCrossRefGoogle Scholar
  9. 9.
    Ryan M, Yule B, Bond C, et al. Knowledge of drug costs: a comparison of general practitioners in England and Scotland. Br J Gen Pract 1992; 42: 6–9PubMedGoogle Scholar
  10. 10.
    Lowy DR, Lowy L, Warner RS. A survey of physicians’ awareness of drug costs. J Med Educ 1972; 147: 349–51Google Scholar
  11. 11.
    Nagurney IT, Braham RL, Reader GG, et al. Physician awareness of economic factors in clinical decision—making. Med Care 1979; 17 (7): 727–36PubMedCrossRefGoogle Scholar
  12. 12.
    Thomas DR, Davis KM. Physician awareness of cost under prospective reimbursement systems. Med Care 1987; 25: 181–4PubMedCrossRefGoogle Scholar
  13. 13.
    Hershey CO, Porter DK, Breslau D, et al. Influence of simple computerized feedback on prescription charges in an ambulatoryclinic: a randomized clinical trial. Med Care 1986; 24: 472–81PubMedCrossRefGoogle Scholar
  14. 14.
    Zelnio RN, Gagnon JP. The effects of price information on physician prescribing patterns: a literature review. Drug Intell Clin Pharm 1979; 13: 156–9PubMedGoogle Scholar
  15. 15.
    Oppenheim GL, Erickson SH, Ashworth C. The family physician’s knowledge of the price of prescribed drugs. J Fam Pract 1981; 12: 1027–30PubMedGoogle Scholar
  16. 16.
    Glickmim L, Bruce E, Caro F, et al. Physician’s knowledge of drug costs for the elderly. J Am Geriatr Soc 1991; 42: 992–6Google Scholar
  17. 17.
    Skipper J, Smoth G, Mulligan J, et al. Physicians’ knowledge of cost: the case of diagnostic tests. Inquiry 1976; 3: 194–8Google Scholar
  18. 18.
    Long MJ, Cummings M, Frisof KB. The role of perceived price in physicians’ demand for diagnostic tests. Med Care 1983; 21: 243–50PubMedCrossRefGoogle Scholar
  19. 19.
    Reekie WD. Price sensitivity of general practitioners. In: Phillips CI, Wolfe IN, editors. Clinical practice and economics. Bath: Pitman, 1977: 169–84Google Scholar
  20. 20.
    Denig P, Haaijer-Ruskamp FM. Do physicians take cost into account when making prescribing decisions? Pharmaco Economics 1995: 8 (4): 282–90CrossRefGoogle Scholar
  21. 21.
    Segal R, Helper CD. Prescribers’ beliefs and values as predictors of drug choices. Am J Hosp Pharm 1982: 39: 1391–7Google Scholar
  22. 22.
    Zelnio RN. The interaction among the criteria physicians use when prescribing. Med Care 1982: 20: 277–85PubMedCrossRefGoogle Scholar
  23. 23.
    Denig P, Haaijer-Ruskamp FM, Zijsling DH. How physicians choose drugs. Soc Sci Med 1988: 27: 1381–6PubMedCrossRefGoogle Scholar
  24. 24.
    Janknegt R, Steenhoek A. Keuzecriteria voor geneesmiddelen bij een ‘eenvoudige cystitis’. Tijdschr Ther Oeneesm Onderz 1988: 13: 204–8Google Scholar
  25. 25.
    Janknegt R, Smelik J, Steenhoek A. Betablokkers: keuzecriteria en produktvoorkeur Resultaten van een onderzoek bij vijftigartsen. Pharm Weekbl 1990: 125: 676–80Google Scholar
  26. 26.
    Miller RR. Prescribing habits of physicians: a review of studies on prescribing of drugs. Drug Intell Clin Pharm 1973: 7: 560–4Google Scholar
  27. 27.
    Caplow T, Raymond JJ. Factors influencing the selection of pharmaceutical products. J Market 1984: 19: 18–9CrossRefGoogle Scholar
  28. 28.
    Epstein AM, Read JL, Winickoff R. Physician beliefs, attitudes and prescribing behaviour for anti—inflammatory drugs. Am J Med 1984: 77: 313–8PubMedCrossRefGoogle Scholar
  29. 29.
    Segal R, Hepler CD. Drug choice as a problem solving process. Med Care 1985: 23: 967–76PubMedCrossRefGoogle Scholar
  30. 30.
    Chinburapa V, Larson LN. Predicting prescribing intention and assessing drug attribute importance using conjoint analysis. J Pharm Mark Manage 1988: 2: 3–18CrossRefGoogle Scholar
  31. 31.
    Chinburapa V, Larson LN. The importance of side effects and outcomes in differentiating between prescription drug products. J Clin Phann Ther 1992: 17: 333–42CrossRefGoogle Scholar
  32. 32.
    Denig P, Haaijer-Ruskamp FM, Wesseling H, et al. Towards understanding treatment preferences of hospital physicians. Soc Sci Med 1993: 36: 915–24PubMedCrossRefGoogle Scholar
  33. 33.
    Taylor RJ, Bond CM. Change in the established prescribing habits of general practitioners: an analysis of initial prescriptionsin general practice. Br J Oen Pract 1991: 41: 244–8Google Scholar
  34. 34.
    Robertson WO. Costs of diagnostic tests: estimates by health professionals. Med Care 1980: 10: 556–9CrossRefGoogle Scholar
  35. 35.
    British National Formulary. London: British Medical Association/Royal Pharmaceutical Society of Oreat Britain, 1990 MarGoogle Scholar
  36. 36.
    Rosett RN, Nelson FD. Estimation of the two—limit probil regression model. Econometrica 1975: 43: 141–6CrossRefGoogle Scholar
  37. 37.
    Maddala GS. Limited—dependent and qualitative variables in econometrics. Cambridge: Cambridge University Press, 1983Google Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Mandy Ryan
    • 1
  • Brian Yule
    • 1
  • Christine Bond
    • 2
  • Ross J. Taylor
    • 2
  1. 1.Health Economics Research Unit, Department of Public HealthUniversity of AberdeenForesterhillScotland
  2. 2.Department of General PracticeUniversity of AberdeenScotland

Personalised recommendations